Jiakun Guo
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dual-Targeted Radionuclide Therapy with 161Tb Instigates Anticancer Immunity in "Cold" Murine Prostate Tumor.
Journal: Molecular pharmaceutics
Published: July 03, 2026
Absorbable microspheres co-delivering HIF-1α inhibitor augment transarterial chemoembolization by reversing tumor hypoxia and immunosuppression.
Journal: Acta biomaterialia
Published: November 04, 2025
Absorbable microspheres sustaining epirubicin and TLR7 agonist release for transarterial chemo-immuno-embolization in liver tumor.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 25, 2025
Naphthalene-containing octreotide radioligand elevates selectivity and radionuclide therapy for somatostatin receptor 2-positive tumor.
Journal: Colloids and surfaces. B, Biointerfaces
Published: May 25, 2025
Long-Acting In Situ Cancer Vaccines by Oncolytic STING-Activating Microgels.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: March 19, 2025
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy.
Dual-targeted alpha therapy mitigates prostate cancer and boosts immune checkpoint blockade therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 01, 2025
Oncolytic microgels with regulated antibody release augment tumor immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 01, 2025
Robust and smart polypeptide-based nanomedicines for targeted tumor therapy.
Journal: Advanced drug delivery reviews
Published: September 08, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026